Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03019770 · ClinicalTrials.gov registry record · NA
Optimizing HIV PrEP Through Shared Decision Making
A NA study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 88
- Enrollment target
NCT03019770 is a NA study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 88 participants.
The verdict
NCT03019770, a NA study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 88 participants
- Enrollment target
Study Summary
The purpose of this study is to test a clinical Decision Aid that will help patients and providers determine if pre-exposure prophylaxis (PrEP) is the right decision. The Decision Aid will be tested in both clinical and non-clinical settings with 80 patient-provider dyads. The investigators hypothesize that the use of the Decision Aid will reduce patient decisional conflict. The investigators predict that it will increase patient and provider knowledge of and intent to initiate PrEP.
Interventions
- BEHAVIORAL PrEP Decision Aid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2017-02-24 |
| Est. Completion | 2018-05-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03019770
The ClinicalTrials.gov registry entry for NCT03019770 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PrEP Decision Aid is the first listed.
NCT03019770 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03019770 about?
NCT03019770 is a clinical study titled "Optimizing HIV PrEP Through Shared Decision Making". The purpose of this study is to test a clinical Decision Aid that will help patients and providers determine if pre-exposure prophylaxis (PrEP) is the right decision. The Decision Aid will be tested in both clinical and non-clinical settings with 80 patient-provider dyads. The investigators hypothes...
What is the current status of trial NCT03019770?
This trial is currently completed. It is a NA study. The enrollment target is 88 participants. The study started on 2017-02-24. Estimated completion is 2018-05-24.
What interventions are being tested in trial NCT03019770?
The interventions under investigation include: PrEP Decision Aid (BEHAVIORAL).
Who is sponsoring clinical trial NCT03019770?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.